ESS vs IONS · P/E 31, rev $1.89B vs rev $226.6M
Essex Property Trust Inc (ESS) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported ESS revenue for 2025-12-31 was $1.89B. Net income was $702.8M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
ESS currently screens at market cap $18.91B and trailing P/E 30.9. IONS currently screens at market cap $12.28B.
Not investment advice. Open the ESS and IONS stock pages for the full models.
Not investment advice.